Effects of pegylated recombinant human megakaryocyte growth and development factor on thrombocytopenia induced by a new myelosuppressive chemotherapy regimen in mice.

Source:http://linkedlifedata.com/resource/pubmed/id/8948025

Download in:

View as

General Info

PMID
8948025